PureTech Health plc (FRA:0VQ)
Germany flag Germany · Delayed Price · Currency is EUR
1.400
0.00 (0.00%)
At close: Nov 28, 2025

PureTech Health Statistics

Total Valuation

PureTech Health has a market cap or net worth of EUR 343.11 million. The enterprise value is 198.09 million.

Market Cap343.11M
Enterprise Value 198.09M

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date Nov 28, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 241.68M
Shares Outstanding n/a
Shares Change (YoY) -11.33%
Shares Change (QoQ) -1.00%
Owned by Insiders (%) 3.58%
Owned by Institutions (%) 75.31%
Float 167.83M

Valuation Ratios

The trailing PE ratio is 7.95.

PE Ratio 7.95
Forward PE n/a
PS Ratio 63.05
PB Ratio 1.09
P/TBV Ratio 1.07
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 4.59
EV / Sales 37.33
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -2.32

Financial Position

The company has a current ratio of 8.49, with a Debt / Equity ratio of 0.44.

Current Ratio 8.49
Quick Ratio 8.35
Debt / Equity 0.44
Debt / EBITDA n/a
Debt / FCF -1.63
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 9.44% and return on invested capital (ROIC) is -14.92%.

Return on Equity (ROE) 9.44%
Return on Assets (ROA) -12.95%
Return on Invested Capital (ROIC) -14.92%
Return on Capital Employed (ROCE) -22.90%
Revenue Per Employee 97,177
Profits Per Employee 770,577
Employee Count56
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

In the past 12 months, PureTech Health has paid 2.61 million in taxes.

Income Tax 2.61M
Effective Tax Rate 8.76%

Stock Price Statistics

The stock price has decreased by -29.29% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -29.29%
50-Day Moving Average 1.45
200-Day Moving Average 1.50
Relative Strength Index (RSI) 49.24
Average Volume (20 Days) 500

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, PureTech Health had revenue of EUR 5.44 million and earned 43.15 million in profits. Earnings per share was 0.17.

Revenue5.44M
Gross Profit -41.56M
Operating Income -99.97M
Pretax Income 29.76M
Net Income 43.15M
EBITDA -98.53M
EBIT -99.97M
Earnings Per Share (EPS) 0.17
Full Income Statement

Balance Sheet

The company has 282.09 million in cash and 139.28 million in debt, giving a net cash position of 142.81 million.

Cash & Cash Equivalents 282.09M
Total Debt 139.28M
Net Cash 142.81M
Net Cash Per Share n/a
Equity (Book Value) 314.22M
Book Value Per Share 1.33
Working Capital 258.70M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -85.40 million and capital expenditures -9,367, giving a free cash flow of -85.41 million.

Operating Cash Flow -85.40M
Capital Expenditures -9,367
Free Cash Flow -85.41M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -1,837.01%
Pretax Margin 546.82%
Profit Margin 792.96%
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PureTech Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 11.33%
Shareholder Yield 11.33%
Earnings Yield 12.58%
FCF Yield -24.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

PureTech Health has an Altman Z-Score of 1.44 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.44
Piotroski F-Score 4